ID: ALA4573395

Max Phase: Preclinical

Molecular Formula: C12H13N3O3

Molecular Weight: 247.25

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COCc1cn(-c2ccc(C(=O)OC)cc2)nn1

Standard InChI:  InChI=1S/C12H13N3O3/c1-17-8-10-7-15(14-13-10)11-5-3-9(4-6-11)12(16)18-2/h3-7H,8H2,1-2H3

Standard InChI Key:  LXRFCBIWZCZAIS-UHFFFAOYSA-N

Associated Targets(non-human)

ORF 73 309 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 247.25Molecular Weight (Monoisotopic): 247.0957AlogP: 1.20#Rotatable Bonds: 4
Polar Surface Area: 66.24Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.64CX LogD: 1.64
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.76Np Likeness Score: -1.74

References

1. Kirsch P, Jakob V, Oberhausen K, Stein SC, Cucarro I, Schulz TF, Empting M..  (2019)  Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8.,  62  (8): [PMID:30888817] [10.1021/acs.jmedchem.8b01827]

Source